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Abstract
The important human pathogen Candida albicans possesses an unusual form of gene regulation, in which the copy number
of an entire specific chromosome or a large portion of a specific chromosome changes in response to a specific adverse
environment, thus, insuring survival. In the absence of the adverse environment, the altered portion of the genome can be
restored to its normal condition. One major question is how C. albicans copes with gene imbalance arising by transitory
aneuploid states. Here, we compared transcriptomes from cells with either two copies or one copy of chromosome 5 (Ch5)
in, respectively, a diploid strain 3153A and its representative derivative Sor55. Statistical analyses revealed that at least 40%
of transcripts from the monosomic Ch5 are fully compensated to a disomic level, thus, indicating the existence of a
genome-wide mechanism maintaining cellular homeostasis. Only approximately 15% of transcripts were diminished
twofold in accordance with what would be expected for Ch5 monosomy. Another minor portion of approximately 6% of
transcripts, unexpectedly, increased up to twofold and higher than the disomic level, demonstrating indirect control by
monosomy. Array comparative genome hybridization revealed that only few out of approximately 500 genes on the
monosomic Ch5b were duplicated, thus, not causing a global up regulation. Dosage compensation was confirmed with
several representative genes from another monosomic Ch5a in the mutant Sor60. We suggest that C. albicans’s unusual
regulation of gene expression by the loss and gain of entire chromosomes is coupled with widespread compensation of
gene dosage at the transcriptional level.
Citation: Kravets A, Qin H, Ahmad A, Bethlendy G, Gao Q, et al. (2010) Widespread Occurrence of Dosage Compensation in Candida albicans. PLoS ONE 5(6):
e10856. doi:10.1371/journal.pone.0010856
Editor: Michael Polymenis, Texas A&M University, United States of America
Received September 18, 2009; Accepted May 5, 2010; Published June 11, 2010
Copyright:  2010 Kravets et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported in part by National Institutes of Health Grant AI29433 and Pfizer Global Pharmaceuticals, Pfizer Inc. to Fred Sherman, as well as
partially supported by P30 AG18254 to Hong Qin. The authors are grateful to the University of Rochester funds that enabled this study. The funders had nor o l ei n
study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: Pfizer Inc., which gave a small grant some time ago to Fred Sherman, had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
* E-mail: elena_bulgac@urmc.rochester.edu
Introduction
Candida albicans is a unicellular fungus that is a benign inhabitant
of the mucosal surfaces of gastrointestinal tract in approximately
two thirds of the healthy human population. In some healthy
individuals, C. albicans causes merely superficial mucosal infections;
however, in hospitals, C. albicans has emerged as an important
pathogen of immunocompromized patients and is associated with
significant morbidity, mortality, and high health-care costs.
C. albicans is an obligate diploid organism with 8 pairs of
chromosomes, whose unusual instability has been systematically
investigated by us and others [1]. Throughout years, we have
accumulated evidence that C. albicans generates aneuploidies as a
response to environmental stresses [1–3], despite aneuploidy having
detrimental effects on cell division and growth similar to other
organisms [4,5]. Moreover, we have demonstrated that reversible
loss or gain of specific chromosomes, or large portions of specific
chromosomes, each occurring in a specific adverse environment,
constitute unusual gene regulatory systems that allow C. albicans
survival [1,2]. In the best-studied case, adaptation to the toxic sugar
sorbose, the major mechanism conferring survival is the loss of an
entire chromosome 5a (Ch5a) or an entire chromosome 5b (Ch5b).
Here, we address an intriguing question of how C. albicans
handles gene disbalance due to aneuploid chromosome by
analyzing the expression of approximately 500 genes on the
monosomic Ch5b. We found that at least 40% of transcripts were
fully compensated to the disomic level, in contrast to another
fungus Saccharomyces cerevisiae. This finding was supported with the
analysis of limited number of genes from the alternative Ch5a.
Using array comparative genome hybridization (aCGH), we
demonstrated that widespread dosage compensation was not
caused by gene duplication. This implies that epigenetic events
may be responsible, similarly to compensatory mechanisms in
higher eukaryotes, as elaborated in the Discussion.
Results
Evidence by pulsed-field gel electrophoresis (PFGE) that
the mutant Sor55 is monosomic for Ch5b
Electrophoretic karyotype [6] of the mutant Sor55, which we
analyzed here with expression or CGH arrays, was previously
reported [7]. Sor55 derived from the laboratory strain 3153A by
exposure to toxic sorbose, which caused the loss of Ch5a. We have
previously established that the loss of an entire Ch5a is a
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this respect, Sor55 is a representative mutant.
In order to assure that we are analyzing the transcriptom from
cells with monosomic, but not with spontaneously duplicated
Ch5b [7], we confirmed the electro-karyotype of Sor55. When
cells of 3153A and Sor55 were grown to extract RNA for
expression microarrays, an aliquot of cells was used to obtain
native chromosomes for precise separation with PFGE [3]
(Materials and Methods). As expected, Sor55 contained Ch5b,
but lacked Ch5a, Fig. 1. The retained Ch5b was not duplicated, as
determined by visual examination and densitometry [3]. In
addition, consistently, PCR analysis showed that only MTLa1
on Ch5b, but not MTLa1 or MTLa2 on Ch5a, could be amplified
from genomic DNA of Sor55 with the appropriate primers [Table
S1 of supporting information (SI)]. As expected, all three genes,
MTLa1, MTLa1 and MTLa2, could be amplified from 3153A.
Also, monosomy of Ch5 has been reported to up regulate the
SOU1 gene on Ch4 that is responsible for the growth on sorbose
[7,8]. As expected, SOU1 in Sor55 was up regulated, as estimated
by DNA microarray (Table S2) and Northern blot analysis (data
not shown). We are, thus, confident that the Sor55 cells were
monosomic for Ch5b at the time of transcriptom examination.
Statistical analysis of the DNA microarray results reveals
significantly diminished expression profile of monosomic
Ch5b
Genome-wide transcription profiles were determined with our
custom microarrays (Materials and Methods) for the Sor55
mutant, monosomic for Ch5b, and for its parental strain 3153A,
disomic for Ch5. ANOVA (analysis of variance) showed that the
influence of GC content of probes is negligible on expression
changes in Sor55, as compared to 3153A. The expression change
of each gene was estimated by either mean or median of the ratio
Sor55/3153A. The p-value was estimated by pairwise t-test for
base-2-log transformed expression signals for all genes along each
chromosome. The data for each chip were normalized by
assuming that the total intensity of all non-Ch5 genes remains
the same. In our microarrays, Ch5 is represented by a total of 507
ORFs, of which 470 are expressed above the background noise in
both 3153A and Sor55 (Material and Methods). The data in
Table 1 show that monosomic Ch5b has, on average, a diminished
expression profile of approximately 15–17%, as estimated by
either mean or median of the ratios Sor55/3153A. The results are
very similar when the expression data were normalized by the total
intensity of all genes including Ch5 genes (data not shown).
Chromosomes other than Ch5b did not have a decrease of overall
expression. A detailed analysis of the genome-wide changes in
expression will be presented elsewhere.
Statistical analysis of the DNA microarray results reveals
that expression of many genes on Ch5b are
compensated to the diploid level, while expression of
some other genes decreased or increased twofold or
more
The expression ratios Sor55/3153A of 470 Ch5b genes that are
above the background noise (see above), comprise an approxi-
mately normal distribution covering a wide continuous range of
values between more than twofold decrease to more than twofold
increase, Fig. 2. This distribution was practically identical to the
distribution that included all 507 Ch5 genes (data not shown). The
values of expression ratios for all Ch5b genes can be accessed in
SI, Table S2. A total of 186, or 40%, of the 470 genes had their
ratios within the range from 0.9 to 1.1, which we considered the
same as the disomic level. Of the remaining 284 genes 75 had
statistically significant changes in expression, as determined with a
p-value=0.05 cutoff. The distribution of the expression ratios of
those 75 genes covered the same wide range, as the distribution of
all 470 genes (data not shown). We, thus, assumed that expression
changes with no statistical significance may have biological
Figure 1. Evidence of Ch5 monosomy in the mutant Sor55 or
Sor60. Electrophoretic karyotype is prepared using a contour-clamped
homogeneous electric field apparatus (Bio-Rad Laboratories, Hercules,
CA). Shown are precisely separated smaller Ch5, Ch6, and Ch7 of the
parental strain 3153A, as well as of its derivatives Sor55 and Sor60.
Homologous chromosomes are designated a or b. Under this running
condition [3] that is optimizing smaller chromosomes, the longer
chromosomes are compressed on the top of a gel. Separation of longer
chromosomes is not presented. Note similar brightness of Ch5a or Ch5b
in all strains (confirmation with densitometry is not presented). In
contrast, a band containing co-migrating Ch6b and Ch7a is stained
approximately twice stronger.
doi:10.1371/journal.pone.0010856.g001
Table 1. Average change of gene expressions by
chromosomes.
Sor55/3153A
Ch Mean Median p-value Gene number
a
1 1.05 1.03 2.7610
26 1346
R 1.04 1.03 0.0026 966
2 1.04 1.02 0.0011 987
3 1.04 1.00 0.019 745
4 1.14 1.10 1.2610
228 661
5 0.86 0.85 1.3610
245 507
6 1.03 1.02 0.31 431
7 1.12 1.06 4.4610
212 406
aGenes with their expression within the background noise are excluded from
calculating mean, median, and p-value, but not from the number of the genes
on each chromosome. ChR refers to the chromosome containing a cluster of
tandemly repeated rDNA units [9].
doi:10.1371/journal.pone.0010856.t001
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example, six chips instead of three were used for the arrays.
Validation of the DNA microarray data for the expression
of 38 genes on monosomic Ch5b
Northern blot and semi-quantitative RT-PCR analyses (Mate-
rials and Methods) were initially used for validation of the
microarray data with two control genes not on Ch5b, EMP24
(orf19.6293) on ChR (the chromosome containing rRNA genes)
and orf19.2087 on Ch2. Both approaches confirmed the results
obtained with the microarrays, showing no change of the
expression ratios Sor55/3153A in these control genes (data not
shown). We next choose at random 38 genes on monosomic Ch5b
with various Sor55/3153A ratios and validated the ratios using
two alternative approaches, as follows: 9 genes with both Northern
blot and semi-quantitative RT-PCR analyses; 9 genes with only
Northern blot; and 19 genes with only semi-quantitative RT-PCR
analysis. Although, the values obtained with these two procedures
agreed with each other and with those obtained with the
microarray procedure, Northern blot analyses showed a larger
variability with lower expressed genes and are, thus, considered
less accurate. For this reason, we present in Table 2 the validation
by RT-PCR for 21 representative genes. Validation by RT-PCR
with all 30 genes or by Northern blot analyses with 21 genes is
presented in supporting information, Tables S3 and S4,
Figure 2. Distribution of expression ratios Sor55/3153A of
Ch5b genes. A total of 470 genes with the expression above the
background noise in our arrays are included. Expression ratio for each
gene is calculated as the mean ratio Sor55/3153A. Expression ratios are
binned along the abscissa. Each bin is 0.1. The number of genes in
corresponding bins is presented along the ordinate.
doi:10.1371/journal.pone.0010856.g002
Table 2. RT-PCR validation
a of the array expression values with 21 genes
b on Ch5b in Sor55
c.
Sor55/3153A, Ch5b Sor60/3153A, Ch5a
Expression on Ch5b Gene Arrays RT-PCR RT-PCR
4-fold up CAG1 3.9 3.9; 4.0; 4.2 5.0; 5.1
2-fold up PGA37 2.1 2.0; 2.0; 2.7
GAP5 1.7 1.4; 1.5; 1.8
CAR1 1.6 1.3; 1.8; 1.8
GAP1 1.6 1.4; 1.6; 1.7
Disomic level HIS1 1.0 1.0; 1.0; 1.0; 1.1 1.1; 1.1
UBC13 1.0 1.0; 1.0; 1.0
ACH1 1.0 1.0; 1.0; 1.0; 1.1
MDJ1 1.0 1.0; 1.0; 1.0
GLR1 1.0 0.8; 0.9; 0.9; 1.0; 1.1
PRE1 1.0 0.8; 0.9; 0.9; 0.9
RPO26 1.0 0.9; 0.9; 1.0
orf19.4248 1.0 0.8; 0.9; 1.0
orf19.4349 1.0 0.8; 0.9; 1.0
CTA24
d 1.0 1.0; 1.0; 1.0; 1.2
Monosomic level SEC14 0.5 0.5; 0.5; 0.5
THS1 0.5 0.5; 0.6; 0.7
orf19.3216 0.5 0.5; 0.6; 0.6
PUT1 0.5 0.3; 0.5; 0.6 0.4; 0.4
URA4 0.5 0.5; 0.6; 0.6
GDS1 0.5 0.2; 0.5; 0.6
aSee Fig. S1 for examples of semi-quantitative RT-PCR gels.
bSee Table S3 for all 30 genes, Table S1 for gene systematic names. For Northern blot analyses see the Results section and Table S4.
cNote that also shown are RT-PCR estimates of the expression level of several corresponding genes on Ch5a in Sor60.
dNote that CTA24 is duplicated on Ch5b in Sor55, Table S2 and legend to Fig. 5, and is serving here, as a control for the expression from two copies of gene. The other
genes have aCGH ratios Sor55/3153A ranging from 0.51 to 0.64 with two ratios equaling to 0.65 and 0.68. Most probably, all those genes possess a single copy.
Expression changes were calculated, as mean ratios Sor55/3153A for Ch5b or Sor60/3153A for Ch5a. Data were obtained from independent experiments.
doi:10.1371/journal.pone.0010856.t002
Dosage Compensation in Candida
PLoS ONE | www.plosone.org 3 June 2010 | Volume 5 | Issue 6 | e10856respectively. Expression changes of only two genes showed
disagreement between microarray and RT-PCR methods, Table
S3.
The validation with two independent methods, Northern blot
and RT-PCR, thus, supports the array results.
Genes with approximately twofold change in expression,
as compared to the diploid level, are scattered along the
entire Ch5b
We prepared the distribution of expression changes along Ch5b
by plotting the expression ratios Sor55/3153A of each gene to its
position on Ch5b, Fig. 3. The genes with twofold or more decrease
or increase, as compared to the diploid level, are in red and blue,
respectively. The remaining genes are in green. It is obvious that
two-fold down regulated or excessively up regulated genes are
randomly located along the entire length of Ch5b with no
clustering.
DNA profiling of the monosomic Ch5b by aCGH
It is important to note that there was no change in the size of the
monosomic Ch5b, as determined with PFGE (Fig. 1 and
‘‘Evidence that the mutant Sor55 is monosomic for Ch5b’’), even,
though a large number of at least 186 genes were up regulated to
the disomic level. If duplication of this number of genes occurred
and duplicated copies were retained on Ch5b, considering the
average gene length as 1 kb, Ch5b would become 186 kb longer.
This value constitutes twice the difference between Ch5a and
Ch5b in the parental strain 3153A, Fig. 1. Such a dramatic event
is easily observed with PFGE. However, we have not excluded the
unlikely possibility that the duplicated genes were transferred to
various other chromosomes. Also, a small number of genes with
the expression levels exceeding the disomic level, especially PGA37
or CAG1 that are up regulated, respectively, twofold or four fold
above the disomic level, Table 2, raised the question of possible
increase of the gene copy number of a subset of genes. Duplicated
copies of the genes could reside on Ch5b or could be dispersed
over different chromosomes. We, thus, investigated in more detail
the copy number of the Ch5b genes in the mutant Sor55 by the
aCGH approach with custom tiling arrays from Roche Nimble-
Gen Inc. (Materials and Methods). The DNA content of Ch5b was
estimated from approximately 20,000 Ch5 probes. When we
calculated the ratio of averaged intensities Sor55/3153A for each
probe from three arrays, we found, as expected, approximately a
half global diminution of DNA across Ch5b. In Fig. 4, this result is
presented by plotting averaged log2 of ratios Sor55/3153A for
each probe according to the position on Ch5. Overall, slightly less
than the expected half DNA diminution on Ch5b is explained by
previously well-documented phenomenon of distortion due to
dynamic range compression on aCGH [10]. By the contrast, an
overall amount of DNA of the control Ch6 corresponded to the
expected disomic level (see Fig. 1). Clearly, the Ch5b DNA content
became monosomic with no large duplicated portions of the
chromosome.
Also, we combined probes mapping inside of ORF of each Ch5
gene and calculated the mean ratio Sor55/3153A for each Ch5b
gene from three arrays (Table S2, Materials and Methods). From
these data, we found at most only three genes on Ch5b,
orf19.2657, CTA24 (orf19.4054), and IMP2 (orf19.1981), which
possessed DNA/DNA ratios approximately 1.0 and which, thus,
could be considered with certainty, as duplicated. Expression
ratios Sor55/3153A of these genes, consistently, corresponded to
the disomic level, Tables 2 and S2. As presented in Fig. 5, in which
Figure 3. Distribution of expression ratios Sor55/3153A of
Ch5b genes along Ch5. The mean expression ratio for each gene is
plotted along the ordinate at the corresponding Ch5 position on the
abscissa. Twofold or more diminished expressions are in red; twofold or
more increased expressions are in blue. The remaining partially or fully
compensated expressions are in green. For more detail see legend of
Fig. 2. A black circle indicates the position of the centromere.
doi:10.1371/journal.pone.0010856.g003
Figure 4. DNA profiling of the monosomic Ch5b by tiling aCGH.
The mean aCGH log2 of the ratio Sor55/3153A for each of
approximately 20,000 tiling probes on Ch5 is plotted according to the
chromosomal position of the probe. Every point of the plot, thus,
corresponds to a probe. Also presented is the similar plot of log2 of
ratios for the Ch6 tiling probes. The horizontal line at position 0 on the
ordinate corresponds to no DNA change. Note the global diminution of
the DNA on Ch5b, but not on the control disomic Ch6 in the mutant
Sor55. See Fig. 1 for the monosomic or disomic condition of,
respectively, Ch5 or Ch6 in Sor55. Note that the absence of MTLa locus
on Ch5b corresponds to dramatic diminutions on aCGH (see section
‘‘Limited analysis of gene expressions on another Ch5a, when it
becomes monosomic in the strain Sor60’’ in Results).
doi:10.1371/journal.pone.0010856.g004
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ratio, the points for these three genes are positioned on the
ordinate clearly apart from the other gene values. A single gene,
SMD3 (orf19.4146), possessed DNA/DNA ratio slightly below 0.8
and was also expressed slightly above the disomic level, 1.17.
Although not as clear, SMD3 could be also considered as
duplicated. Strikingly, the majority of the genes with high
expressions exceeding the disomic level clearly possessed a single
DNA copy; aCGH ratios raging between 0.5 and 0.6.
The large majority of genes, their expressions distributing
between haploid and diploid levels, possessed DNA/DNA ratios
distributed around 0.5 and 0.6, which is a clear indication of a
single gene copy. A total of 62 genes possessed DNA/DNA ratios
slightly varying around 0.7. However, we cannot interpret this
ratio, as a clear indication of gene duplication, because the
expression levels of those genes distributed over different levels
including six genes that were down regulated to 50%. Taking into
account the above, as well as the phenomenon of the compression
on aCGH, we believe that most of those genes are not duplicated.
We confirmed the haploid copy number of four genes with
Southern blot analysis. These genes were expressed at the
monosomic or disomic level, SEC14 or MDJ1, respectively, as
well as twofold or four fold above the disomic level, PGA37 or
CAG1, respectively, Table 2. Each of these genes was used to
prepare probes that were subsequently hybridized with blots
containing either total digested DNA or native chromosomes (for
detail see SI).
Our aCGH chips lacked a total of six genes that were, however,
present on expression arrays, Table S2. Even if those genes were
all duplicated, an unlikely possibility, a duplication of a minimum
of only 10 genes or, if combined with some possibly duplicated
genes with ratios 0.7 (see above), a maximum of, for example, 20
genes out of approximately 186 fully normalized genes is certainly
not important for considering the generalization of widespread up
regulation due to dosage compensation.
Limited analysis of gene expressions on another Ch5a,
when it becomes monosomic in the strain Sor60
We have asked whether dosage compensation also occurs on the
alternative monosomic Ch5a. Similarly to Ch5b of the mutant
Sor55, we confirmed the monosomic condition of Ch5a of the
mutant Sor60 with electro-karyotyping followed by densitometry
(Fig. 1; see above). The electro-karyotype was prepared with an
aliquot of cells that were grown for RNA extraction. Semi-
quantitative RT-PCR was used to prepare expression ratios
Sor60/3153A from Ch5a with three genes representing three
major expression levels on Ch5b. As presented in Table 2, we
confirmed that, similarly to the Ch5b, on alternative Ch5a, CAG1
is excessively over expressed, up to 5 fold, HIS1 is normalized to
the disomic level, and PUT1 is approximately half-diminished.
Discussion
Aneuploidy is responsible for many human genetic diseases,
appears in most cancer cells and correlates with tumorigenicity.
Clearly, in simple organisms, such as C. albicans, studies of gene
expression in aneuploid cells, in particular of genes residing on
aneuploid chromosomes, may facilitate the understanding of the
mechanisms operating in higher eukaryotes and are of wide
interest. Studying the expression of genes on monosomic Ch5 in C.
albicans is also of special interest, as Ch5 monosomy is a means of
survival under certain condition (see Introduction).
Statistical analysis of the genome-wide transcriptome responses
to Ch5b monosomy revealed that 125 of 5,542 non-Ch5 genes
(2%) significantly changed their expression level with p-values less
than 0.01. These changes, however, did not lead to a decrease of
overall chromosome expression. In contrast to these chromo-
somes, the monosomic Ch5b exhibited a significant decrease of
expression to approximately 83–85% of the level of two
chromosomes, but not 50%, as might be expected. The lesser
decrease resulted from various changes in expression for different
genes: decrease for some genes and no change or even increase for
some other genes. Specifically, 15% of genes were down regulated
approximately twofold (0.2–0.6); 40% were expressed at various
levels between a twofold decrease and no change (0.7–0.8); 40%
were fully compensated to the level of the disomic strain (0.9–1.1)
(among these genes a few were duplicated, see Results); and 6%
were up regulated above the disomic level up to twofold (1.2–2.1)
with one peculiar gene, CAG1, up regulated four-fold (3.9). Thus,
multiple regulatory mechanisms, not only Ch5b monosomy, are
acting upon Ch5b genes in different ways. Multiple mechanisms
are also implied by the normal distribution of the expression ratios
Sor55/3153A of Ch5b genes shown in Fig. 1. The generality of
dosage compensation on Ch5 was confirmed with a limited
number of genes on the alternative Ch5a.
We assume that, as estimated by a rigorous approach, a large
number of fully compensated transcripts on monosomic Ch5,
40%, is important for maintaining cellular homeostasis. Because
these transcripts represent a large portion of the Ch5 genes, which
are scattered along Ch5, the regulatory system responsible for this
dosage compensation can be considered to be robust, performing
global regulation across the chromosome. (In this regard, see
below for dosage compensation in Drosophila).
Figure 5. Combined plots for the expression and CGH ratios
Sor55/3153A of Ch5b genes. The mean ratios Sor55/3153A for each
Ch5b gene from the expression and CGH arrays are plotted,
respectively, on the abscissa and on the ordinate. Every point of the
plot, thus, corresponds to a gene. On the ordinate, three outstanding
points that are positioned close to 1 indicate duplication of the genes
orf19.2657, CTA24 (orf19.4054), and IMP2 (orf19.1981). The other five
outstanding points that are positioned close to 0 correspond to the
genes of MTLa locus that were lost on Ch5a in Sor55. The few points
below 0.4 are indicative of the poor hybridization on aCGH. On the
abscissa, most importantly, the larger majority of the points represent-
ing the genes, which are up regulated above the disomic level,
expression ratio 1, are represented by a single copy, i. e., aCGH ratios
ranging between 0.4 and 0.6. Also, all the remaining categories of the
gene expression, down regulated, normalized, and intermediate are
represented by the aCGH ratios that are tightly distributed around 0.5–
0.6 for a single DNA copy.
doi:10.1371/journal.pone.0010856.g005
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range between monosomic and disomic levels, could result from
different events: i) partial compensation in order to match to the
expression of the other slightly down regulated genes of the
corresponding pathways; ii) failure to fully compensate due to an
incomplete execution of compensatory mechanism(s). The group
of genes that are expressed between monosomy and disomy needs
further clarification.
A relatively small group of genes, 15%, that are down regulated
twofold or more contrasts with the approximately three times larger
group of fully compensated genes. According to the Candida
Genome Database (CGD) (http://www.candidagenome.org),
many of the twofold down regulated genes are regulatory or
metabolic and are implicated in either biosynthetic processes or
translation, which is indicative of the overall decrease of
metabolism of Sor55. Establishing more direct relevance of these
genes to survival on sorbose medium needs further investigation.
While the twofold decrease could be explained by simple loss of
DNA and represents a direct result of the monosomy, twofold and
more up regulation of genes from another outstanding small
group, 6%, could be due to interactions with other genes on
various chromosomes representing an inverse affect of monosomy.
A specific nature of these up regulated genes may be related to
adaptation to sorbose; however this relationship at present remains
obscure.
Surprisingly, there is a striking similarity between our data and
some of the results with cancer cells. Platzer et al. [11] analyzed
four major amplifications of entire chromosomes or chromosome
arms 7p, 8q, 13q, and 20q in liver metastases of colon cancer.
Among more than 2,000 unique array targets within amplified
chromosomes, only a small fraction, 3.8% of the genes, was up
regulated twofold, two genes were up regulated five-fold, and,
surprisingly, 7.7% of the genes were down regulated twofold,
whereas the vast majority of the genes were expressed between
twofold decrease and twofold increase suggesting that they are
partially or fully compensated to the disomic level, despite the
chromosomal amplifications. In the prostate tumor cell line,
Phillips et al. [12] identified multiple chromosomal rearrangements
including duplications, amplifications, loss of entire chromosomes
or chromosome arms, as well as non-reciprocal translocations. An
overall significant association of approximately one half of down or
up regulated genes with, respectively, DNA gain or loss was
established. Although, changes in expression of the genes mapping
within the aneuploid regions ranged from less than twofold to
more than twofold, as compared to the disomic level, only a few
genes were up regulated more that twofold on duplicated or
amplified chromosomes. Also, there were cases of inversely
regulated genes, 14% down regulated in regions of DNA gain
and 9% up regulated in regions of DNA loss.
Similarly, Makarevitch et al. [13] recently found selective dosage
compensation on a chromosome acquiring triploid arm in plants:
40% of the genes were up regulared at a level that is expected for
the trisomy, 1.5-fold; however, 60% exibited no changes, while a
few genes were up regulated more than twofold compared to the
disomic level.
Dosage compensation has been predominantly studied with
heteromorphic sex chromosomes in species in which females possess
twogene-richlargeX chromosomes(XX),whereasmalespossessone
X and one gene-poor small Y. Various mechanisms equalizing X
genes with genes on autosomes and between males and females were
uncovered in mammals, the fly Drosophila melanogaster and the worm
Caenorhabditis elegans. For example, one X in female mammals is
practically silent; while the active X is globally up regulated in both
females and males. The latter is in contrast to the fly or the worm
where the single X in males is up regulated, whereas in the XX
hermaphrodite worm, both Xs are partially repressed [14–16].
Dosage compensation for sex-chromosomes is thought to have
evolved in order to prevent debilitating gene disbalance, as
dramatically exemplified with various human diseases due to
aneuploidy of sex-chromosomes, autosomes or portions of chromo-
somes [17,18]. Surprisingly, recent studies with several species of
birds having ZZ males and ZW females have challenged this idea
[19,20]. The dosage compensated and non-compensated genes
occurred across Z in females, diminishing the overall Z expression to
approximately 80% of the ZZ level in males.
Dosage compensation in the fly is currently well understood.
The males-specific lethal (MSL) complex of proteins and non-
coding RNAs binds to hundreds of sites along X in transcription-
coupled fashion allowing a key component of MSL, a protein
MOF, to acetylate histone H4 at lysine 16. The activity of MSL is
thought to facilitate hyper-transcription by leading to more open
chromatin structure. Furthermore, transcription-coupled methyl-
ation of histone H3 at lysine 36 enhances recruitment of MSL
[21,22]. On the other hand, in females dosage compensation is
inhibited by the female-specific RNA-binding protein Sex lethal
(SXL) [23].
In contrast to higher eukaryotes, dosage compensation at the
transcriptional level has not been found in lower eukaryotes, such
as the yeast Saccharomyces cerevisiae. By studying large collection of
laboratory strains, Hughes et al. [24] identified twenty aneuploid
strains, in which expression of nearly every gene on a trisomic or a
monosomic chromosome was correspondingly altered. Torres et al.
[5] created a collection of haploid S. cerevisiae strains that each bear
an extra copy of one or more of chromosomes. An approximate
doubling of gene expression along the entire length of duplicated
disomic chromosomes was observed. Although no compensatory
mechanisms at the level of transcription was revealed, the authors
found that the amounts of many, but not all analyzed proteins, did
not increase, thus, indicating the cell’s attempt to restore its normal
physiological state.
In this study, we demonstrated that in a lower eukaryote C.
albicans, regulation by Ch5 monosomy is coupled with a
widespread compensation of the gene dosage at a transcriptional
level. Such coupling obviously diminishes detrimental consequenc-




The laboratory strain 3153A has been largely used to study
chromosome aneuploidy [1]. Its derivative Sor55 is a representa-
tive mutant that is monosomic for Ch5b [1,6], whereas the
derivative Sor60 is monosomic for Ch5a.
Custom designed expression microarrays from
CombiMatrix Corporation
CombiMatrix Corporation (Mukilteo, WA) designed DNA
microarrays, as based on 6,321 open reading frames (ORF) found
in assembly 19 of the C. albicans genome sequence (http://
sequence-www.stanford.edu; http://www.candidagenome.org/).
The ‘‘CustomArray
TM 12 K’’ microarrays have been provided
to us by CombiMatrix Corporation (http://www.combimatrix.
com/products_customarray.htm). The CustomArray
TM uses a
specially modified semiconductor where electrical currents deliv-
ered to the platinum pads create a localized proton flux that acts as
a chemical deprotectant for in situ phosphoramidite synthesis. The
reactions on each pad are digitally controlled and allow directing
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oligonucleotides are between 35–40 nucleotides; whereas the other
10% are longer. The oligonucleotides were predominantly
designed to correspond to the 59-and 39-regions of the ORFs.
Furthermore, out of the approximately 80 single nucleotide
polymorphisms, which map to Ch5 sequences, only one occurred
in the same location as one of the probes. Each chip contains
11,898 unique probes that are spread across 12,000 spots. The
ORFs on Ch5 are represented at least twice. Each chip also
contains 544 standard control probes, of which 395 are exogenous
sequences not found in C. albicans.
Hybridization to expression microarray chips and
handling of chips
Three batches of total RNA were prepared for each strain, using
independent cultures (see Supporting Information S1 for more detail).
2 mg of total RNA from each batch was used to synthesize Cy5-
dUTP labeled anti-sense RNA, using the Ambion Amino Allyl
Message Amp II aRNA Amplification Kit (Ambion, Austin, TX).
Anti-sense RNA was hybridized to an individual chip as recom-
mended by CombiMatrix Corporation (http://www.combimatrix.
com); the hybridization was carried out in the Functional Genomics
Center at the University of Rochester Medical Center. The chips
were scanned with a ScanArray Lite microarray laser scanner (Perkin
Elmer, Boston, MA) at a 5 mm resolution. The resulting 16-bit TIFF
files were quantified with Microarray Imager software (CombiMatrix
Corporation, Mukilteo, WA).
Analysis of transcriptional profiling by DNA microarrays
Data from three independent experiments were combined and
statistically analyzed with a custom-designed program. Statistical
analysis scripts were written in R for normalization, ANOVA,
significance tests, and visualization. Genome annotation was
parsed from CGD. Because each ORF from Ch5 was spotted
twice on each chip, six signal intensity ratios Sor55/3153A were
compared. The signal intensities of the 395 control non-C. albicans
probes (see above) were treated as non-specific hybridization and
the median of their values on each chip is taken as the background
signal. Because the standard deviation of negative control probes is
approximately 200 on all chips, genes with expression levels ,200
are considered in the same levels as background noise and are
excluded from estimation of expression level changes. The signal
intensities of annotated genes are obtained after subtraction of the
background signal from their raw values. The background-
corrected signals are then normalized by assuming that the total
combined signals of non-Ch5 genes on each chip remain constant,
because genes on monosomic Ch5 are expected to change their







   :
Sum of non-Ch5 gene signals in reference chip
Sum of non-Ch5 gene signals in the k-th chip
,
where si,k is the signal for gene i on k-th chip, and J is the number
of probes for gene i. This constant normalization method (or
scaling method) is often the most biologically consistent method
[25]. When calculating the expression ratio Sor55/3153A,
negative signals are considered as 1. The final ratio is the average
of the paired hybridizations experiments. Pair-wise t-test was
performed using the base-2-log transformations of the scaled-
signals from three hybridizations in both Sor55 and 3153A. Raw
data are available at Gene Expression Omnibus (GEO), http://
www.ncbi.nlm.nih.gov/geo/, with the accession numbers
GSM455127-GSM455132.
Custom designed CGH microarrays from Roche
NimbleGen Inc.
Roche NimbleGen Inc. (Madison, WI) designed tiling DNA
microarrays for the C. albicans genome supercontigs (assembly 19
f r o mt h eC G D ) .T h eH X 3m i c r o a r r a y sh a v eb e e np r o v i d e dt ou sb y
Roche NimbleGen Inc. (http://www.nimblegen.com/). Each micro-
array contains 710,907 probes that were permitted to match up to
four times within the genome. Of all probes, approximately 20,000
matched the Ch5 sequences. The probes were in-situ synthesized 50-
mers with an average probe spacing of 35 bp on each strand. The
design was tiled in an unbiased fashion across the entire genome. The
number of probes per gene varied depending on the size of the gene.
Empty features on the array were filled with randomly generated
probes that had G+Ccontentand length comparable totheC. albicans
probes and that acted as controls for non-specific binding.
Hybridization to CGH microarrays and handling of chips
In order to increase statistical confidence, independent batches
of total DNA were prepared using independent cultures for each
strain, Sor55 or 3153A. A total of 10 mg of DNA from each strain
were sonicated per Nimblegen’s instructions, using a Branson
model 450 Sonifier, resulting in a mean size of ,500 bp. The
sheered DNA was quality checked on a 2% agarose gel. Labeling
was performed as recommended by Nimblegen, using, as two
separate 2 mg of DNA reactions for each strain with either Cy3 or
Cy5 conjugated random nanomers for 2 hours at 37uC. The
labeled targets were dried and re-suspended in NimbleGen
hybridization buffer. A total of 31 mg of each labeled DNA
samples, Sor55 and 3153A, were combined and hybridized with
each array at 42uC for 72 hours in the NimbleGen Hybridization
System. The arrays were washed, as recommended by manufac-
turer, and dried using an Array-It mini-centrifuge. The arrays
were scanned on a NimbleGen MS 200 Microarray Scanner at a
resolution of 2 mm (49 pixels/13 mm feature) and resulted in a
40% increase in signal/noise, as measured by mad.1dr. Signal
intensities were extracted from the scanned images using
NimbleScan 2.5. Briefly, spatial correction was applied to adjust
for possible signal intensity variance across the surface of the array
then normalization was performed to compensate for differential
signal intensities between Cy3 and Cy5 dyes.
Analyses of genome profiling by aCGH microarrays
Functional Genomics Center at the University of Rochester
Medical Center analyzed hybridization data from two indepen-
dent DNA batches of 3153A or Sor55 that were labeled,
respectively, with Cy3 or Cy5, as well as one dye-swap. The
normalized intensity ratios Sor55/3153A for each probe were
averaged from three arrays to form a single data point. Data were
highly consistent between three arrays. The Sor55/3153A ratios
from these genomic probes reflect the relative copy number of the
corresponding genomic loci. In addition, the mean ratio Sor55/
3153A for each gene on Ch5b was prepared from the mean values
of the probes tiling inside of the corresponding ORF. The number
of such probes per ORF varied dependent on the gene size. Raw
data are available at GEO with the accession number GSE21616.
Northern blot analysis
General approaches for Northern analysis were adopted from
Ding et al. [26]. Each transcript was examined at least 3 times
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Images were visualized using PhosphorImager Storm-820 (Mo-
lecular Dynamics, Sunnyvale, CA). Individual bands were
quantified using ImageQuant 5 software (Molecular Dynamics,
Sunnyvale, CA). For more detail see SI.
RT-PCR analysis
Total RNA was additionally treated with RNase free DNase to
remove all traces of genomic DNA. Semi-quantitative RT-PCR
analysis is described in [27,28]. Briefly, each transcript was
examined from several different RNA batches and same or
different internal controls. Control genes were selected according
to the following criteria: residing outside Ch5; no expression
change in Sor55 and similar expression level to the studied gene;
the absence of amplification inhibition and non-specific bands
while co-amplifying; a close match of the number of cycles
required for both amplicons to reach the exponential phase [28]
(see SI for the enzyme use and for more detail). Genes of interest
and control genes were amplified in the same tube for different
number of cycles, Fig. S1. The images of amplicons from several
consecutive cycles in exponential phase were used for densitom-
etry. Studied gene was normalized against the control gene by
calculating mean ratio of densitometry values.
Various procedures
For preparation of total RNA see SI. Preparation and analysis
of electro-karyotype, cell transformation, as well as procedures that
diminish undesirable chromosome instability were carried out, as
previously reported [3,29]. For genes and primers used in this
work see Table S1.
Supporting Information
Supporting Information S1
Found at: doi:10.1371/journal.pone.0010856.s001 (0.03 MB
DOC)
Figure S1 Analysis of RT-PCR products amplified from total
RNA of strains 3153A and Sor55 using primers for CAG1,
orf19.4349, and URA4.
Found at: doi:10.1371/journal.pone.0010856.s002 (1.12 MB
TIF)
Table S1 List of genes and primers.
Found at: doi:10.1371/journal.pone.0010856.s003 (0.07 MB
DOC)
Table S2 Expression arrays
a and aCGH values calculated as
mean ratios Sor55/3153A for all Ch5b genes.
Found at: doi:10.1371/journal.pone.0010856.s004 (1.05 MB
DOC)
Table S3 RT-PCR validation
a of the expression array values
with 30 genes
b on Ch5b in Sor55.
Found at: doi:10.1371/journal.pone.0010856.s005 (0.05 MB
DOC)
Table S4 Northern blot validation of the array expression values
with 18 genes
a on Ch5b in Sor55.
Found at: doi:10.1371/journal.pone.0010856.s006 (0.03 MB
DOC)
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